Sphera Funds Management Ltd. Verona Pharma PLC Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $496,799 - $1.63 Million	120,000 New	120,000 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$3.55 - $5.06 $2.37 Million - $3.37 Million	-666,339 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.82 - $6.98 $650,299 - $941,720	-134,917 Reduced 16.84%	666,339 $3.33 Million
Q1 2021 May 17, 2021	SELL	$7.08 - $9.33 $1.65 Million - $2.17 Million	-232,347 Reduced 22.48%	801,256 $6.7 Million
Q4 2020 Feb 16, 2021	BUY	$5.51 - $8.11 $185,152 - $272,520	33,603 Added 3.36%	1,033,603 $7.24 Million
Q3 2020 Nov 12, 2020	BUY	$4.45 - $10.2 $4.45 Million - $10.2 Million	1,000,000 New	1,000,000 $6.24 Million

167

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.75B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.